Inside Global Fabry Academy (GFA) 2025
At GFA 2025, we explored the latest research, advancements, and innovations in Fabry disease with an international panel of Fabry experts. Whether you attended the event or are visiting the post-event hub to catch up on what you missed, this page will provide you with valuable insights and highlights from the sessions.
GFA provided a forum to exchange clinical experiences and knowledge amongst peers through interactive workshops, Q&As and panel discussions. Our goal was to foster collaboration amongst attendees to help shape the future of Fabry care and inspire the next generation of Fabry experts.
From the Experts: Watch Top Doctors Discuss Key Research
We’re excited to share video highlights from a selection of the sessions, providing you key knowledge and insights from the esteemed speakers.
Decoding Fabry Disease: Genetic Variants and Their Impact
Listen to Prof. Dominique P. Germain, MD, PhD, Director of the Reference Center for Fabry Disease and Lysosomal Diseases at the University of Versailles, France, discuss his perspective on insights gained about genetic variants in Fabry disease.
In this talk, Prof. Germain talks at length about genotype-phenotype correlations, galactosidase alpha (GLA) variants, precision medicine in Fabry disease, variants of unknown significance, and much more.
MAT-BE-2501224-1.0-11/2025
The Fabry Disease Journey: Past, Present, and Future with AI
Listen to Prof. Maurizio Pieroni, MD, PhD, FESC, from the Cardiomyopathy Unit of Careggi University Hospital – University of Florence, Italy, and Prof. James Moon, MD, PhD, of Bart’s Heart Center, London, discuss their perspective on enhancing Fabry disease prognosis using traditional cardiac parameters and AI.
In this talk, Prof. Pieroni and Prof. Moon talk at length about the Fabry disease journey to date, from enzyme replacement therapy (ERT) approval in 2001, to prognostic stratification using imaging predictors of adverse prognosis, discussing the future applications of AI in Fabry disease.
MAT-BE-2501225-1.0-11/2025
Timing is Everything: Initiating Treatment for Female and Pediatric Fabry Patients
Listen to Dr. Sima Canaan-Kühl, senior consultant in Clinical Nephrology and Hypertension at Charité, University Hospital Berlin, Germany, and Prof. Marco Spada, Assistant Professor, Department of Public Health and Pediatrics, University of Turin, Italy, discuss the timing of Fabry-specific treatment initiation in female and pediatric Fabry patients.
Dr. Canaan-Kühl and Prof. Spada discuss how to identify the priority signs and symptoms across all organ systems in female patients, and key concepts for the management of pediatric Fabry disease.
MAT-BE-2501226-1.0-11/2025
Relaterade sidor
A heart for Fabry – Podcast om hjärtat och Fabrys sjukdom
A podcast series designed by cardiologists, for cardiologists and other healthcare professionals.
Building Care webinar series
The Building Care webinar series is designed to deepen your understanding of the critical role a patient-centered, multidisciplinary approach plays in managing Fabry disease.
SE-FILMEN-HÄR
